Month: March 2014

SACRAMENTO, Calif. (AP) — As the happy hour crowd poured in on a recent weeknight, the kitchen and bar staff at Hock Farm restaurant scrambled to meet the incoming orders.

Some of the weight–loss organisations are actually owned by food companies … and high-fat meals for sustained weight loss and optimal health …

If you think of climate change as a hazard for some far-off polar bears years from now, you're mistaken. That's the message from top climate scientists gathering in Japan this week to assess the impact of global warming.

By Michelle Nichols UNITED NATIONS (Reuters) – The United Nations accused Syria's government and rebels of hindering aid access, suggesting both sides could be violating U.N. Security Council demands that emergency relief reach civilians caught in the crossfire of the three-year civil war. A month after the 15-member council achieved rare unity to unanimously approve a resolution demanding rapid, safe and unhindered aid access, including across borders, U.N. chief Ban Ki-moon said the situation "remains extremely challenging." In Ban's first report to the council on the implementation of the February 22 resolution – obtained by Reuters on Sunday – he said 175,000 people remain besieged by government forces and 45,000 people trapped by opposition groups in several areas. No new ceasefires were brokered to gain access to these areas and there were breaches of existing ceasefires, Ban said. Some 9.3 million people in Syria need humanitarian assistance, Ban said, while another 2.6 million have fled the three-year civil war, sparked in March 2011 by a revolt against President Bashar al-Assad.

Israel-based BrainStorm Cell Therapeutics said on Monday the U.S. Patent and Trademark Office has granted the company a key patent for its autologous stem cell technology. The patent covers BrainStorm’s stem cells induced to secrete elevated levels of neurotrophic factors for the treatment of neurodegenerative diseases. Pending approval from the U.S. Food & Drug Administration, the company is preparing for its upcoming mid-stage Phase II trial in the United States with its NurOwn adult stem cell therapy. BrainStorm is developing NurOwn for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease, a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.

The best advice is to find a healthy eating regime – let's call it a diet – that … Weight–loss diets that give you a meal plan, such as those designed by …

LONDON (Reuters) – Britain’s healthcare cost agency has recommended against using Bayer’s new prostate cancer drug Xofigo on the state health service because the German firm did not provide evidence on how well it worked compared to other therapies. The draft guidance from the National Institute for Health and Care Excellence (NICE), issued on Monday, is now subject to consultation. “We are disappointed not to able to recommend this drug, but we have to be confident that its benefits justify its considerable cost,” said NICE Chief Executive Andrew Dillon. …